Orphan Drugs: From Neglected Diseases to a Global Mission

Rare diseases, affecting fewer than one in 2,000 people, may seem like a small percentage, but they collectively impact over 300 million individuals worldwide. Unfortunately, only about 5% of these conditions have approved treatments, leaving many patients feeling isolated and alone.

Arphio are on a mission to change this narrative, by improving patient access to vital treatments for rare diseases. As a B2B pharmaceutical manufacturer specializing in orphan drugs, we believe in collaboration and ethical innovation to create a lasting impact in the lives of those affected.

"Our vision at Arphio is rooted in a deep sense of responsibility towards rare disease patients. We believe that together, we can transform the lives of millions by making crucial treatments accessible worldwide," says Dr. Shlomo Sadoun, CEO of Arphio.

Arphio’s foundation is built on collaboration, recognizing that the best results stem from combining expertise and market reach. Arphio partners with leading specialists in the development of orphan products to make life-changing treatments available to a broader international population. By connecting the dots between therapeutics in development and those available in selected countries, we ensure that vital treatments reach those who need them most.

Arphio's singular focus lies in rare disease detection, market access, and the supply of orphan drugs internationally. We specialize in genetic, hematology, oncology, and other diseases where effective therapies are currently limited. Our unwavering commitment is to create a portfolio of innovative treatments, making them accessible to a wider global population.

The importance of orphan drugs is underscored by the industry's growth, with global sales projected to rise from US$128 Bn to US$217 Bn between 2019 and 2024. As pioneers in this field, we recognize the significance of our mission and the immense potential it holds.

"Rare – but not alone" encapsulates Arphio’s commitment to patients, empowering them with proper diagnostics and reaching every individual, irrespective of geographic location, ethnicity, socioeconomic status, color, or gender. Our holistic approach begins with identifying the cause of the disease and continues with proper detection and diagnostics, ensuring maximum agility to reach as many patients as possible.

We are seeking partners and employees who share our futuristic approach to create a profound impact on rare disease patients and caregivers globally. Our company culture is rooted in ethics, compliance, accessibility, and corporate governance, promoting a patient-centric approach and upholding the highest ethical and professional standards.

Be a part of our mission to transform the lives of millions affected by rare diseases. Stay informed about Arphio's progress by subscribing to our newsletter or reaching out to us directly. Join us on our journey towards a healthier and brighter future for rare disease patients. Together, we can create positive change and improve access to vital treatments worldwide.